111 related articles for article (PubMed ID: 9183665)
41. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome.
Bouscary D; Fontenay-Roupie M; Chretien S; Hardy AC; Viguié F; Picard F; Melle J; Dreyfus F
Br J Haematol; 1995 Oct; 91(2):425-7. PubMed ID: 8547088
[TBL] [Abstract][Full Text] [Related]
42. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of EVI-1 in blast crisis of chronic myeloid leukemia.
Carapeti M; Goldman JM; Cross NC
Leukemia; 1996 Sep; 10(9):1561. PubMed ID: 8751483
[No Abstract] [Full Text] [Related]
44. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
Fuchs O
Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
[TBL] [Abstract][Full Text] [Related]
45. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
[TBL] [Abstract][Full Text] [Related]
46. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
47. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
Yuan X; Wang X; Bi K; Jiang G
Int J Oncol; 2015 Dec; 47(6):2028-36. PubMed ID: 26496831
[TBL] [Abstract][Full Text] [Related]
48. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
Suzukawa K; Parganas E; Gajjar A; Abe T; Takahashi S; Tani K; Asano S; Asou H; Kamada N; Yokota J
Blood; 1994 Oct; 84(8):2681-8. PubMed ID: 7919381
[TBL] [Abstract][Full Text] [Related]
49. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?
Breccia M; Petti MC; Ottaviani E; Mancini M; D'Elia GM; Mecarocci S; Alimena G
Br J Haematol; 2002 Aug; 118(2):438-41. PubMed ID: 12139729
[TBL] [Abstract][Full Text] [Related]
50. Expression of the Evi-1 gene in myelodysplastic syndromes.
Dreyfus F; Bouscary D; Melle J; Ribrag V; Guesnu M; Varet B
Leukemia; 1995 Jan; 9(1):203-5. PubMed ID: 7845018
[TBL] [Abstract][Full Text] [Related]
51. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.
Perkins AS; Fishel R; Jenkins NA; Copeland NG
Mol Cell Biol; 1991 May; 11(5):2665-74. PubMed ID: 2017172
[TBL] [Abstract][Full Text] [Related]
52. [Molecular study of bone marrow chimerism and expression of EVI-1 gene as manifestations of minimal residual disease after bone marrow transplantation (BMT)].
Jółkowska J; Witt M
Med Wieku Rozwoj; 1999; 3(1):139-52. PubMed ID: 10910646
[TBL] [Abstract][Full Text] [Related]
53. Oncogenes and leukemia.
Butturini A; Gale RP
Leukemia; 1990 Feb; 4(2):138-60. PubMed ID: 2406517
[TBL] [Abstract][Full Text] [Related]
54. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
55. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
Morishita K; Parganas E; Matsugi T; Ihle JN
Mol Cell Biol; 1992 Jan; 12(1):183-9. PubMed ID: 1370341
[TBL] [Abstract][Full Text] [Related]
56. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.
Wang W; Cortes JE; Lin P; Beaty MW; Ai D; Amin HM; McDonnell TJ; Ok CY; Kantarjian HM; Medeiros LJ; Hu S
Blood; 2015 Oct; 126(14):1699-706. PubMed ID: 26243778
[TBL] [Abstract][Full Text] [Related]
57. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
[TBL] [Abstract][Full Text] [Related]
58. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
[TBL] [Abstract][Full Text] [Related]
59. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
60. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML).
Privitera E; Longoni D; Brambillasca F; Biondi A
Leukemia; 1997 Dec; 11(12):2045-8. PubMed ID: 9447818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
